Feature|Videos|January 9, 2025
Reflecting on the COVID-19 Pandemic Response
Lessons from the COVID-19 response highlight regulatory collaboration, research expansion, and challenges in vaccine access and preparedness.
Advertisement
Episodes in this series
A lot can be learned from the COVID-19 response, including global regulatory collaboration, de-risking pharmaceutical development, and expanding research participation. This segment covers challenges such as sustaining preparedness and addressing vaccine access inequities.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
Cellares Extends Cell Therapy Automation Beyond T Cell Therapies
3
Containment to Protection: Packaging Trends Impacting Biopharma
4
FDA Clears Affinia’s AFTX-201 for Phase I/II BAG3 Cardiomyopathy Trial
5